Niva Bupa Health Insurance Company Ltd (NIVABUPA) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company reported a strong H1 FY26, with an overall Gross Written Premium (GWP) growth of 23% and a retail growth of 28% on a like-to-like basis (without 1/N impact), demonstrating robust business momentum.
- Profitability saw a significant improvement, with IFRS Profit After Tax (PAT) for H1 more than doubling to INR 132 crores from INR 60 crores in the same period last year, driven by operating leverage and expense management.
- The combined insurance service ratio under IFRS improved by 105 basis points to 103.1% for H1 FY26, indicating enhanced operational efficiency despite a slight increase in the overall loss ratio.
- The company maintained its retail market share at 9.9% and continued to focus on high-value policies, with 83% of policies having a sum insured of INR 1 million or above and an industry-leading average ticket size (ATS) of over INR 31,000.
- Strategic initiatives progressed well, including the launch of the ReAssure 3.0 product, expansion of the Preferred Provider Network (PPN), and significant investments in technology, such as setting up an AI lab and launching a new microservices-based core system.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.